We plan to begin the subject review in October 2018. We will perform this review to meet the annual reporting requirements of Public Law 105-277, “Office of National Drug Control Policy Reauthorization Act of 1998.” The objective of the review is to attest to whether the funds that the DoD obligated for the National Drug Control Program in FY 2018 are reported, in all material respects, in accordance with the Office of National Drug Control Policy Circular, “Accounting of Drug Control Funding and Performance Summary,” May 8, 2018. We will conduct sufficient work to express a conclusion and provide limited assurance regarding the presentation of the funds obligated by the DoD for the National Drug Control Program for FY 2018. To provide limited assurance, the procedures we perform will be generally limited to inquiries and analytical procedures.